Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multicenter randomized trial of amnioinfusion].

W Fraser1, S Marcoux, W Prendiville

  • 1CHUQ-PSFA, Unité des Essais Cliniques, 10 rue de l'Espinay, local D1-724, Québec G1L 3L5, Canada. william.fraser@ogy.ulaval

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|May 11, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An operational framework for wildlife health in the One Health approach.

One health (Amsterdam, Netherlands)·2024
Same author

Standardizing a method for functional assessment of neural networks in brain organoids.

Journal of neuroscience methods·2024
Same author

Randomised controlled trial of analgesia for the management of acute severe pain from traumatic injury: study protocol for the paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN).

Scandinavian journal of trauma, resuscitation and emergency medicine·2023
Same author

Generation of an iPSC line (FINi001-A) from a girl with developmental and epileptic encephalopathy due to a heterozygous gain-of-function p.R1882Q variant in the voltage-gated sodium channel Na<sub>v</sub>1.2 protein encoded by the SCN2A gene.

Stem cell research·2023
Same author

Correction: An online parenting intervention to prevent affective disorders in high-risk adolescents: the PIPA trial protocol.

Trials·2022
Same author

No exponential rise in revision knee replacement surgery over the past 15 years: an analysis from the National Joint Registry.

Osteoarthritis and cartilage·2022

Amnioinfusion may reduce complications from meconium-stained amniotic fluid during labor. This study investigates its effectiveness in preventing neonatal death and meconium aspiration syndrome, offering crucial insights for maternal and infant care.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Clinical Trials

Background:

  • Meconium-stained amniotic fluid (MSAF) is a common complication during labor.
  • MSAF increases the risk of neonatal and maternal morbidity, including meconium aspiration syndrome (MAS).
  • Amnioinfusion is a potential intervention to mitigate MSAF-related risks.

Purpose of the Study:

  • To determine if amnioinfusion reduces perinatal death or moderate-to-severe MAS in cases of thick MSAF.
  • To evaluate the impact of amnioinfusion on other neonatal morbidity indicators and cesarean section rates.
  • To assess women's childbirth experiences and the economic implications of amnioinfusion.

Main Methods:

  • A multi-center, randomized controlled trial involving approximately 50 obstetrical centers globally.

Related Experiment Videos

  • Participants will be randomized to receive either amnioinfusion or standard care for thick MSAF.
  • Outcomes include perinatal death, MAS severity, neonatal morbidity, cesarean rates, maternal satisfaction, and economic analysis.

    • Main Results:

    • This section is to be filled upon study completion.

    Conclusions:

    • This study aims to provide essential data on the efficacy and effectiveness of amnioinfusion for MSAF.
    • Findings will inform clinical practice guidelines regarding the management of MSAF during labor.